Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients

American Journal of Tropical Medicine and Hygiene

Volumn 57, Issue 2, 1997, Pages 168-171

  Luz, Kleber G ^a   Da Silva, Valdemir O ^b   Gomes, Elza M ^b   Machado, Fatima C S ^b   Araujo, Mauricio A F ^b   Fonseca, Henrique E M ^c   Freire, Telma C ^d   D'Almeida, Jose B ^a   Palatnik, Marcos ^b   Palatnik De Sousa, Clarisa B ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Hemovida Blood Bank   (Brazil)

^d Hemonorte Blood Bank   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BRAZIL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; HUMAN; LEISHMANIA DONOVANI; LEISHMANIASIS; MAJOR CLINICAL STUDY; PARASITE TRANSMISSION; PSYCHODIDAE; RISK FACTOR;

LEISHMANIA DONOVANI; NASO HEXACANTHUS; PROTOZOA; PSYCHODIDAE;

EID: 0030790320     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.57.168     Document Type: Article

References (16)

1. Modabber F, 1993. Leishmaniasis. World Health Organization, ed. Tropical Disease Research Progress. 1991-1992. Geneva: World Health Organization, 77-87.
2. Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barrai A, Teixeira R, Johnson WDJ, 1986. New perspectives on a sub-clinical form of visceral leishmaniasis. J Infect Dis 156: 1003-1011.
3. Andre R, Brumpt L, Dreyfus B, Passeleq A, Jacob S, 1958. Leishmaniose cutanle, leishmaniose cutanle-ganglionnaire et kala-azar transfusionnel. Trop Dis Bull 55: 379-381.
4. Cummins D, Amin S, Halil O, Chiodini PL, Hewitt PE, Radley-Smith R, 1995. Visceral leishmaniasis after cardiac surgery. Arch Dis Child 72: 235-236.
5. Cohen C, Corazza F, De Mol P, Brasseur D, 1991. Leishmaniasis acquired in Belgium. Lancet 338: 128.
6. Mauny I, Blanchot I, Degeilh B, Dabadie A, Guiguen C, Roussey M, 1993. Visceral leishmaniasis in an infant in Brittany: discussion of the modes of transmission out of endemic zones. Pediatr Bucur 48: 237-239.
7. Palatnik-de-Sousa CB, Paraguai de Souza E, Gomes EM, Soares Machado FS, Luz KG, Borojevic R, 1996. Transmission of visceral leishmaniasis by blood transfusion in hamsters. Braz J Med Biol Res 29: 1311-1315.
8. Grogl M, Daugirda JM, Hoover DL, Magill AJ, Berman JD, 1993. Survivability and infectivity of viscerotropic Leishmania tropica from Operation Desert Storm participants in human blood products maintained under blood bank conditions. Am J Trop Med Hyg 49: 308-315.
9. Pampiglione S, Manson-Bahr PEC, Giungi F, Giungi G, Perenti A, Canestri Trotti G, 1974. Studies on Mediterranean leishmaniasis. II. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg 68: 447-453.
10. Palatnik-de-Sousa CB, Gomes EM, Paraguai de Souza E, Palatnik M, Luz KG, Borojevic R, 1995. The fucose mannose ligand of Leishmania donovani in diagnosis and prognosis of visceral leishmaniasis (Kala-azar). Trans R Soc Trop Med Hyg 89: 390-393.
11. Palatnik CB, Borojevic R, Previato JO, Mendonca-Previato L, 1989. Inhibition of Leishmania donovani internalization into murine macrophages by chemically defined parasite glycoconjugate ligands. Infect Immun 57: 754-763.
12. Palatnik-de-Sousa CB, Dutra HS, Borojevic R, 1993. Leishmania donovani surface glycoconjugate GP36, is the major immunogen component of the fucose mannose ligand (FML). Acta Trop 53: 59-72.
13. Palatnik CB, Previato JO, Mendonca-Previato L, Borojevic R, 1990. A new approach to phylogeny of Leishmania: species specificity of glycoconjugate ligands for promastigote internalization into murine macrophages. Parasite Res 76: 289-293.
14. Palatnik-de-Sousa CB, Gomes EM, Paraguai de Souza E, Santos WR, Macedo SR, Medeiros LV, Luz KG, 1996. The FML (fucose mannose ligand) of Leishmania donovani. A new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar. Rev Soc Bras Med Trop 29: 153-163.
15. Ayoola EA, Huraib S, Arif M, AL-Faleh FZ, Al-Rashed R, Ramia S, Al-Mofleh IA, Abu-Aisha H, 1991. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. J Med Virol 35: 155-159.
16. Schulman IA, 1994. Parasitic infections and their impact on blood donor selection and testing. Arch Pathol Lab Med 118: 366-370.